{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:06:47Z","timestamp":1790719607946,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ajp.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T12:11:03Z","timestamp":1520079063000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Clozapine use in geriatric patients\u2014 Challenges"],"prefix":"10.1016","volume":"33","author":[{"given":"Shiva Shanker Reddy","family":"Mukku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0010-440X(99)90134-7","article-title":"Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy","volume":"40","author":"Barak","year":"1999","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40266-013-0144-2","article-title":"Adverse effects of clozapine in older patients: epidemiology, prevention and management","volume":"31","author":"Bishara","year":"2014","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0015","first-page":"12","article-title":"Clozapine use in female geriatric patients with psychoses","volume":"8","author":"Chengappa","year":"1995","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"Suppl","key":"10.1016\/j.ajp.2018.03.008_bib0020","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1007\/BF00442574","article-title":"Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies","volume":"99","author":"Claas","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.ajp.2018.03.008_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-198712000-00002","article-title":"The risks and benefits of clozapine versus chlorpromazine","volume":"7","author":"Claghorn","year":"1987","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9169","key":"10.1016\/j.ajp.2018.03.008_bib0030","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(99)00860-0","article-title":"Clozapine in drug-induced psychosis in Parkinson\u2019s disease. The French Clozapine Parkinson study group","volume":"353","author":"Clozapine in drug-induced psychosis in Parkinson\u2019s disease","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.ajp.2018.03.008_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SPC.0b013e32832ea6ae","article-title":"Advances in the treatment of neutropenia","volume":"3","author":"Dale","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ajp.2018.03.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-015-0366-3","article-title":"Chronic constipation in the elderly: a primer for the gastroenterologist","volume":"15","author":"De Giorgio","year":"2015","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.ajp.2018.03.008_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","article-title":"Clozapine-related seizures","volume":"41","author":"Devinsky","year":"1991","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ajp.2018.03.008_bib0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2165\/00003495-199040050-00007","article-title":"Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia","volume":"40","author":"Fitton","year":"1990","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/j.ajp.2018.03.008_bib0055","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotic drugs: a critical overview","volume":"172","author":"Gardner","year":"2005","journal-title":"CMAJ: Can. Med. Assoc. J."},{"issue":"5","key":"10.1016\/j.ajp.2018.03.008_bib0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00044011-200323050-00001","article-title":"Conventional and atypical antipsychotics in the elderly: a review","volume":"23","author":"Gareri","year":"2003","journal-title":"Clin. Drug Investig."},{"issue":"5","key":"10.1016\/j.ajp.2018.03.008_bib0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.7.5.525","article-title":"The safety of clozapine in the elderly","volume":"7","author":"Gareri","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0070","first-page":"73","article-title":"Association of clozapine with seizures: a brief report involving 222 patients prescribed clozapine","volume":"25","author":"Grover","year":"2015","journal-title":"East Asian Arch. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2013.05.001","article-title":"Risk of neutropenia in a clozapine-treated elderly population","volume":"148","author":"Guenette","year":"2013","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.ajp.2018.03.008_bib0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00048679709073852","article-title":"Is clozapine safe in the elderly?","volume":"31","author":"Herst","year":"1997","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"Suppl. 12","key":"10.1016\/j.ajp.2018.03.008_bib0085","first-page":"22","article-title":"A historical perspective of clozapine","volume":"60","author":"Hippius","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/JGP.0b013e3182118318","article-title":"Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia","volume":"20","author":"Ismail","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0095","first-page":"223","article-title":"Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy","volume":"52","author":"Kamphuis","year":"2010","journal-title":"Tijdschrift Voor Psychiatrie"},{"issue":"9","key":"10.1016\/j.ajp.2018.03.008_bib0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.9758\/cpn.2016.14.4.323","article-title":"Clozapine monitoring in clinical practice: beyond the mandatory requirement","volume":"14","author":"Kar","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002826-200301000-00003","article-title":"Clozapine in Parkinson\u2019s disease psychosis: 5-year follow-up review","volume":"26","author":"Klein","year":"2003","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0922-4106(93)90126-T","article-title":"Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists","volume":"245","author":"Kuoppam\u00e4ki","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4088\/JCP.v60n0108","article-title":"Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics","volume":"60","author":"Lane","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2018.03.008_bib0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0891988707303335","article-title":"Clozapine for treatment-resistant agitation in dementia","volume":"20","author":"Lee","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"9896","key":"10.1016\/j.ajp.2018.03.008_bib0130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet (London England)"},{"issue":"11","key":"10.1016\/j.ajp.2018.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.npp.1300768","article-title":"N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors","volume":"30","author":"Li","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10398562.2010.525646","article-title":"Clozapine use in Australia","volume":"19","author":"Malalagama","year":"2011","journal-title":"Australas. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/10398560903254193","article-title":"Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context","volume":"18","author":"Malhi","year":"2010","journal-title":"Austral. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0897190007304982","article-title":"Antipsychotic medication use in the elderly patient","volume":"20","author":"Malone","year":"2007","journal-title":"J. Pharm. Pract."},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1345\/aph.17215","article-title":"Atypical antipsychotics part I: pharmacology, pharmacokinetics, and efficacy","volume":"33","author":"Markowitz","year":"1999","journal-title":"Ann. Pharmacother."},{"issue":"Suppl. B","key":"10.1016\/j.ajp.2018.03.008_bib0160","first-page":"47","article-title":"An overview of the mechanism of action of clozapine","volume":"55","author":"Meltzer","year":"1994","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2018.03.008_bib0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.psc.2007.04.008","article-title":"Real-world antipsychotic treatment practices","volume":"30","author":"Moore","year":"2007","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.ajp.2018.03.008_bib0170","first-page":"4","article-title":"Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition?","volume":"2014","author":"Munshi","year":"2014","journal-title":"Case Rep. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.8.1.1","article-title":"Clozapine as a treatment for psychosis in Parkinson\u2019s disease: a review","volume":"8","author":"Musser","year":"1996","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ajp.2018.03.008_bib0180","series-title":"Psychosis and Schizophrenia in Adults-use of Clozapine, Guidance and Guidelines","author":"National Institute for Health and Care Excellence NICE","year":"2015"},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.ajp.2018.03.008_bib0190","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.44.12.2247","article-title":"Clozapine-related seizures: experience with 5,629 patients","volume":"44","author":"Pacia","year":"1994","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ajp.2018.03.008_bib0195","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease","volume":"340","author":"Parkinson Study Group","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1041610214001756","article-title":"Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia","volume":"27","author":"Pridan","year":"2015","journal-title":"Int. Psychogeriatr."},{"issue":"3","key":"10.1016\/j.ajp.2018.03.008_bib0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002826-199706000-00003","article-title":"Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson\u2019s disease","volume":"20","author":"Ruggieri","year":"1997","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.ajp.2018.03.008_bib0210","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.1998.00822.x","article-title":"Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance","volume":"46","author":"Schaber","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ajp.2018.03.008_bib0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060863","article-title":"Prevalence and predictors of clozapine-Associated constipation: a systematic review and meta-analysis","volume":"17","author":"Shirazi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0220","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YIC.0b013e32834405fc","article-title":"A study of the use of clozapine in old age psychiatry","volume":"26","author":"Snowdon","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2018.03.008_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.10.011","article-title":"Results of phase 3 of the CATIE schizophrenia trial","volume":"107","author":"Stroup","year":"2009","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.ajp.2018.03.008_bib0230","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1176\/appi.ajp.161.9.1620","article-title":"Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics","volume":"161","author":"Tauscher","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0019-5545.31607","article-title":"Clozapine-induced cardiac failure","volume":"48","author":"Thomas","year":"2006","journal-title":"Indian J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2018.03.008_bib0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2045125311405566","article-title":"Clozapine-related EEG changes and seizures: dose and plasma-level relationships","volume":"1","author":"Varma","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2018.03.008_bib0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2018.03.008_bib0250","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.40.5.832","article-title":"Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis","volume":"40","author":"Wolters","year":"1990","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ajp.2018.03.008_bib0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2042098613486829","article-title":"Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies","volume":"4","author":"de Jong","year":"2013","journal-title":"Ther. Adv. Drug Saf."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201818300625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201818300625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:29:30Z","timestamp":1761755370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201818300625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":51,"alternative-id":["S1876201818300625"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2018.03.008","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine use in geriatric patients\u2014 Challenges","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}